FoundationOne® CDx, on the other hand, includes the percentage of genomic LOH (%LOH > 16) and next-generation sequencing of 315 genes, including HR-related genes extending beyond BRCA1/2, and other cancer-related genes such as NOTCH and MTOR [33,65]. This evidence concerns the gene BRCA1 and cancer.